A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse

NCT01846481 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Dependence
Opioid Related Disorders
Cocaine Dependence

Interventions

DRUG: RBP-8000 100 mg
DRUG: Placebo
DRUG: Cocaine
DRUG: RBP-8000 200 mg

Sponsor

Indivior Inc.